REGN Jan 2025 700.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:08PM EDT. Market open.
| Previous close | 243.30 |
| Open | 243.30 |
| Bid | 286.60 |
| Ask | 295.20 |
| Strike | 700.00 |
| Expiry date | 2025-01-17 |
| Day's range | 243.30 - 243.30 |
| Contract range | N/A |
| Volume | |
| Open interest | 81 |
Insider MonkeyRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $9.55 EPS, expectations were $10.17. Regeneron Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to […]
Simply Wall St.Regeneron Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations
Regeneron Pharmaceuticals ( NASDAQ:REGN ) First Quarter 2024 Results Key Financial Results Revenue: US$3.15b (flat on...
- GuruFocus.com
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
Discover how Regeneron sustains robust growth with significant advancements in clinical programs and strategic market maneuvers.
© 2024 Yahoo. All rights reserved.